subsidiary · medical-implant · neurostimulation
Cortigent
At a glance
- Legal name
- —
- Aliases
- Vivani Cortigent
- Type
- subsidiary
- Focus areas
- medical-implant, neurostimulation, therapeutic, prosthetic
- Founded
- —
- Defunct
- —
- Spinout of
- —
- HQ city
- Valencia
- HQ country
- US
- Employees
- —
- Flagship device
- cortigent-orion
- Product lines
- 1
- In-house manufacturing
- Yes
- Open source
- No
- GitHub org
- —
- Website
- cortigent.com
- Blog
- —
- Support
- —
Devices
Milestones
Second Sight + Nano Precision Medical merger forms Vivani Medical; Cortigent is the cortical-prosthesis line
Orion 6-year Early Feasibility Study concludes
Six subjects (UCLA + Baylor) implanted 2018–2019 demonstrated safety and efficacy improvements with Orion vs sham.
Reputation
Direct successor to Second Sight's cortical-prosthesis programme; positions Orion as the technically superior follow-up to the discontinued Argus II by stimulating the visual cortex directly rather than the retina.